维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="BANERJI U"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The association of chemotherapy induced neutropenia on treatment outcomes in small ceLl lung cancer显示文摘	Banerji U Ashley S Coward J	2006	Lung Cancer2006，54，3：	1
2	Braf and nras mutations in melanoma:Potential relationships to clinical response to hspg0 inhibitors显示文摘	Banerji U Affolter A Judson I	2008	Mol Cancer Ther2008，7，4：	1
3	Targeting the molecular chaperone heat shock protein 90 (HSP90) :lessons learned and fu- ture directions显示文摘	HONG D BANERJI U TAVANA B	2013	Cancer Treat Rev2013，39，4：	1
4	Pharmacokinetic- pharmaeodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models 显示文摘	Banerji U Walton M Raynaud F	2005	Clin Cancer Res2005，11，191：	1
5	Phase I pharmacoki netic and pharmacodynamie study of 17 allylamino, 17-deme thoxygeldanamycin in patients with advanced malignancies显示文摘	Banerji U O'Donnell A Scurr M	2005	Clin Oncol2005，23，18：	1
6	Heat shock pmtein 90 as a drug target : some like it hot 显示文摘	Banerji U	2009	Clin Cancer Res2009，15，1：	1
7	The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer显示文摘	Banerji U Ashley S Coward J		0，，3：	1
8	Combinatorial drug therapy tbr cancer in the post - genomic era 显示文摘	A1 - Lazikani B Banerji U Workman P	2012	Nat Biotechnol2012，30，7：	1
9	Heat shock protein 90 as a drug target: some like it hot显示文摘	Banerji U	2009	Clin Cancer Res2009，15，1：	1
10	The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer显示文摘	BANERJI U ASHLEY S COWARD J	2006	Lung Cancer2006，54，3：	1
11	Heat shock protein 90 as a drug target: Some Like It Hot显示文摘	Banerji U	2009	Clin Cancer Res2009，15，1：	1
12	Targeting the molecular chaperone heat shock protein 90(HSP90):lessons learned and future directions显示文摘	Hong DS Banerji U Tavana B	2013	Cancer Treat Rev2013，39，4：	1
13	Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17ACG) in human colon cancer models 显示文摘	Chung Y L Troy H Banerji U	2003	J Natl Cancer Inst2003，95，21：	1
14	Phase Ⅰ pharmacokinetie and pharmacodynamic study of 17 allylamino 17-demethoxy- geldanamycin in patients with advanced rnalignancies显示文摘	Banerji U O'Donnell A Scurr M	2005	Journal of Clinical Oncology2005，23，18：	1
15	The association ofchemo- therapy induced neutropenia on treatment outcomes in small cell lung cancer显示文摘	Banerji U Ashley S Coward J	2006	Lung Cancer2006，54，3：	1
16	Phase I pharmacokinetic and pharmacodynamic studyof17-allylamino,17-demethoxygeldanamycin in patients with advanced malignancies显示文摘	Banerji U O'Donnell A Scurr M	2005	J Clin Oncol2005，23，18：	1
17	Combinatorial drug therapy for cancer in the post-genomic era 显示文摘	A1-Lazikani B Banerji U Workman P	2012	Nat Biotechnol2012，30，7：	1
18	Magnetic resonance spectroscopic pharmacodynamic markersof the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin(17AAG)in hunman colon cancer models显示文摘	Chung YL Troy H Banerji U	2003	J Nat Cancer Inst2003，95，21：	1
19	The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer显示文摘	Banerji U Ashley S Coward J	2006	Lung Cancer2006，54，3：	1
20	Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-Allylamino,17-Demethoxygeldanamycin (17AAG) in human colon cancer models显示文摘	Chung YL Troy H Banerji U	2003	J Natl Cancer Inst2003，95，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示